Clinical Trials Browser

Glioblastoma × durvalumab × CNS × Clear all

Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Glioblastoma, Glioma, Melanoma, Prostatic Neoplasms, Thyroid Neoplasms, Central Nervous System Neoplasms, Cholangiocarcinoma

NCT02336165 2022-10-12

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Phase 2 Completed

159 enrolled 23 charts

CNS

Glioblastoma

NCT02794883 2022-04-18

Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma

Phase 2 Completed

36 enrolled 13 charts

CNS

Glioblastoma, Glioma

Clinical Trials

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma